Hormone Replacement Therapy
HRT stands for Hormone Replacement therapy.
At the age of 20, the production of hormones is at peak and the body performs well according to its need. The human body in early 20 operated like a well-oiled machine.
But with the passage of time the human body becomes less productive due to shortage or lower production of the hormone.
Hormone Replacement Therapy is all about maintaining and balancing the Hormone.
Nowadays Hormone Replacement Therapy for Men and Women are trending in the treatment of shortage of testosterone in male and the level of progesterone and testosterone in females respectively.
In Male, Hormone Replacement Therapy is used to maintain and control the level of Testosterone to boost up men’s health.
Testosterone hormone replacement therapy benefits:
Testosterone is the male hormone primarily produced in man’s testicles.
- Increase sex drive
- Fats distribution with more muscles
- Strong bones with good deposition of Calcium
- Increased Sperm production
- Better Libido
Hormone Replacement therapy is also associated with the treatment of Female Menopause.
HRT is also known as menopausal hormone therapy (MHT) or postmenopausal hormone therapy (PHT, PMHT).
HRT was started in the 1940s but it became most effective and widely used in the 1960s.
HRT was a revolution in the management and treatment of Female menopause.
Reason of Menopause:
When women approach late 30, her ovaries start to make fewer amounts of Estrogen and progesterone hormones that are the reproductive hormones and regulate menstruation.
Menopause is not an illness but a transition.
During this transition, Estrogen and progesterone hormone level fluctuate greatly.
HRT is prescribed to treat those women who have symptoms of Menopause.
HRT for menopause contains both estrogen and progesterone.
Sometimes it contains just estrogen.
Symptoms of Menopause:
Around menopause many female experience different symptoms like
- Hot Flashes
- Vaginal Dryness
- Sleeping Problem leading to insomnia
- Anxiety and depression
- Skin Aging
- Bone loss
- Thinning hairs and hair loss
- Sexual dysfunction
- Bone loss
- Muscles mass deceased
- Mood swing
- Short term memory Issues
- Genito-urinary problems
These Symptoms can start a year before a menstrual bleeding stop and can persist four years after the last bleeding/period.
The main Medicational hormones used in HRT for menopause symptoms are progesterone and Estrogen.
Progesterone is also a manufactured hormone used in the treatment of Menopausal hormone therapy.
Benefits of HRT:
HRT helps you got relief in vaginal issues like Thinning tissues and dryness.
- Improvement in Mental Health
- Lower the risk of Osteoporosis
- HRT regulates and preserves BMD at skeletal sites and reduces the chances of fracture in the Vertebral column and non- vertebral column.
- Decreased risk of colorectal cancer.
- Improve Cardiovascular Health and reduce
- HRT is better and effective treatment at reducing vasomotor symptoms
- Improves moods and even show good result in depressive symptoms
- HRT is effective in vaginal atrophy
- Vaginal Symptoms are improved and
- HRT is the first-line treatment against Osteoporosis
- HRT has a proliferative effect on Urethral epithelium and bladder
- Estrogen has a favorable effect on increasing the HDL cholesterol level and decreasing the LDL cholesterol level.
- According to The National Institute for Health and Care Excellence (NICE), HRT does not increase the risk of Heart disease under the age of 60 if a woman gets started with HRT.
- HTR enhance mental health and Muscle mass maintenance and enhancement
- HRT reduces the long term risk of Alzheimer’s disease.
Side Effects of Hormone Replacement Therapy?
Due to the high dose and inappropriate management of HRT leads to several problems.
Always choose best and experienced Obstetricians-gynaecologists for Hormone Replacement Therapy.
Main risks of HRT are:
- Thromboembolic disease (venous thromboembolism (VTE)
- Pulmonary embolism
- Breast Cancer or Swelling
- Mood Changes
- Vaginal Bleeding
You and your healthcare should balance the risk and benefits you have.
How to get started on HRT?
Consult from experienced GP (General practitioner) if you are interested in HRT.
You can start HRT as soon as you feel symptoms of menopause.
Your GP will explain the different types of available HRT and which one is suitable for you according to your needs.
Start with a low dose and after that, you can increase it.
It may take a few weeks to show its effect when you start treatment.
Who should not use HRT?
HRT will not be suitable if you:
- Have a history of ovarian cancer, breast cancer, and womb cancer
- Have a history of blood clots
- Have a history of Malabsorption
- Uncontrolled blood pressure (Hypertension)
- Liver disease
- Gallbladder disease
If you have some problems that are mentioned above, an alternative to HRT is recommended.
Does it cause weight gain?
Some women worry about HRT leading to weight gain, but still, there is no evidence to support this idea.
A healthy diet and plenty of exercises will help you to control your weight.
Types of Hormone Replacement Therapy Available:
There are more than 50 types of TRT available.
Different types provide different combinations and options according to symptoms.
Most common type are including:
- Estrogen-only HRT Cyclical also known as sequential HRT
- Continuous HRT
- Local estrogen
General practitioners or doctors suggest a low dose of estrogen for those women who have had a hysterectomy and bilateral oophorectomy.
The daily pills and patches are being used and it is popular.
In this case, progesterone is not required because it is used for the lining of the uterus.
Estrogen/Progesterone/Progestin Hormone Therapy:
This is known as combination therapy.
It combines doses of estrogen and progesterone, the synthetic form of progesterone is used in this type of Therapy.
A combination of Progesterone with estrogen lowers the risk of endometrial cancer.
It is used for those women who still have their uterus.
How to take HRT?
Doctors prescribed the lowest dose at the first stage for trial and error basis according to patient symptoms.
These are the way through which HRT can deliver
- Skin Patches
- Vaginal rings
- Gels or creams
When a patient has recovered and no need for HRT it depends on the Doctor that how he will gradually stop the HRT treatment.
Various lifestyle can help women to control and adjustment of menopause symptoms.
- Avoid Spicy Food
- Avoids smoking
- No alcohols and caffeine
- Used loose clothes
- Control sleeping habits
- Regular exercise and some stress reduction techniques like yoga, meditation.
HRT is a standard and less risky technique with some specific hormone and combination of hormones to maintain body functionality like it was in young age.
HRT can help to manage symptoms of menopause.
However, HRT is not for everyone.
Doctors and health care providers can briefly describe their pros and cons according to your symptoms.
These are the resources through which I have collect information. It’s up to you, you can publish these links/references on your website.
- National Institute of Aging. (2017). What Is Menopause? https://www.nia.nih.gov/health/what-menopause
- NHS UK. (2018). Overview – Menopause. https://www.nhs.uk/conditions/menopause/
- National Institute for health and care excellence. (2015). Benefits and risks of HRT. nice.org.uk/guidance/ng23/ifp/chapter/Benefits-and-risks-of-HRT
- Nananda F. Col. et al. (2005). Menopausal hormone therapy after breast cancer: a meta-analysis and critical appraisal of the evidence. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175064/
- Greiser et al. (2004). Menopausal hormone therapy and risk of breast cancer: A meta-analysis of epidemiological studies and randomized controlled trials.https://academic.oup.com/humupd/article/11/6/561/779943.
- Li et al. (2008). Relationship between Menopausal Hormone Therapy and Risk of Ductal, Lobular, and Ductal-Lobular Breast Carcinomas.https://cebp.aacrjournals.org/content/17/1/43.
- Carrasquilla et al. (2017). Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.https://www.ncbi.nlm.nih.gov/pubmed/29149179
- Løkkegaard E. et al. (2017). Risk of Stroke With Various Types of Menopausal Hormone Therapies: A National Cohort Study. Stroke.https://www.ncbi.nlm.nih.gov/pubmed/28626058
- Menopausal hormone therapy (adult). Mayo Clinic; 2019.
- Martin KA, et al. Treatment of menopausal symptoms with hormone therapy. https://www.uptodate.com/contents/search. Accessed March 25, 2020.
- Martin KA, et al. Menopausal hormone therapy: Benefits and risks. https://www.uptodate.com/contents/search. Accessed March 25, 2020.
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 141: Management of menopausal symptoms. Obstetrics & Gynecology. 2014; doi:10.1097/01.AOG.0000441353.20693.78. Reaffirmed 2018.
- North American Menopause Society. The 2017 hormone therapy position statement of The North American Menopause Society. Menopause. 2017; doi:10.1097/GME.0000000000000921.
- North American Menopause Society. Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society. Menopause. 2015; doi:10.1097/GME.0000000000000546.
- Cobin RH, Goodman NF; American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on Menopause – 2017 Update. Endocr Pract. 2017 Jul23(7):869-880. doi: 10.4158/EP171828.PS.
- Avis NE, Crawford SL, Greendale G, et al; Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med. 2015 Apr175(4):531-9. doi: 10.1001/jamainternmed.2014.8063.
- Menopause: diagnosis and management; NICE Guidelines (November 2015)
- Faubion SS, Kuhle CL, Shuster LT, et al; Long-term health consequences of premature or early menopause and considerations for management. Climacteric. 201518(4):483-91. doi: 10.3109/13697137.2015.1020484. Epub 2015 Apr 7.
- Bassuk SS, Manson JE; Oral contraceptives and menopausal hormone therapy: relative and attributable risks of cardiovascular disease, cancer, and other health outcomes. Ann Epidemiol. 2015 Mar25(3):193-200. doi: 10.1016/j.annepidem.2014.11.004. Epub 2014 Nov 13.
- Hickey M, Elliott J, Davison SL; Hormone replacement therapy. BMJ. 2012 Feb 16344:e763. doi: 10.1136/bmj.e763.
- Studd J; Hormone therapy for reproductive depression in women. Post Reprod Health. 2014 Dec20(4):132-7. doi: 10.1177/2053369114557883. Epub 2014 Nov 14.
- Edwards D, Panay N; Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition? Climacteric. 2015 Dec 26:1-11.
- Calleja-Agius J, Brincat MP; The urogenital system and the menopause. Climacteric. 2015 Oct18 Suppl 1:18-22. doi: 10.3109/13697137.2015.1078206.
- Pines A, Shapiro S; Long-term menopausal hormone therapy and health consequences – how to choose sides? Climacteric. 201518(4):441-3. doi: 10.3109/13697137.2015.1041756. Epub 2015 May 11.
- Gambacciani M, Levancini M; Hormone replacement therapy and the prevention of postmenopausal osteoporosis. Prz Menopauzalny. 2014 Sep13(4):213-20. doi: 10.5114/pm.2014.44996. Epub 2014 Sep 9.
- Cauley JA; Estrogen and bone health in men and women. Steroids. 2015 Jul99(Pt A):11-5. doi: 10.1016/j.steroids.2014.12.010. Epub 2014 Dec 30.
- Marjoribanks J, Farquhar C, Roberts H, et al; Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev. 2012 Jul 117:CD004143. doi: 10.1002/14651858.CD004143.pub4.
- Bagger YZ, Tanko LB, Alexandersen P, et al; Two to three years of hormone replacement treatment in healthy women have long-term preventive effects on bone mass and osteoporotic fractures: the PERF study. Bone. 2004 Apr34(4):728-35.
- Harvey RE, Coffman KE, Miller VM; Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Womens Health (Lond Engl). 2015 Mar11(2):239-57. doi: 10.2217/whe.14.64.
- Schierbeck L; Primary prevention of cardiovascular disease with hormone replacement therapy. Climacteric. 201518(4):492-7. doi: 10.3109/13697137.2015.1034098. Epub 2015 Apr 16.
- Schierbeck LL, Rejnmark L, Tofteng CL, et al; Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial. BMJ. 2012 Oct 9345:e6409. doi: 10.1136/bmj.e6409.
- LaRosa JC; Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women? Womens Health Issues. 1992 Summer2(2):102-11
- Rossouw JE, Anderson GL, Prentice RL, et al; Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trial. JAMA. 2002 Jul 17288(3):321-33.
- Lavasani S, Chlebowski RT, Prentice RL, et al; Estrogen and colorectal cancer incidence and mortality. Cancer. 2015 Sep 15121(18):3261-71. doi: 10.1002/cncr.29464. Epub 2015 Jun 2.
- Morch LS, Lidegaard O, Keiding N, et al; The influence of hormone therapies on colon and rectal cancer. Eur J Epidemiol. 2016 Jan 12.
- Wang ZX, Lloyd AA, Burket JC, et al; Altered distributions of bone tissue mineral and collagen properties in women with fragility fractures. Bone. 2016 Jan 15. pii: S8756-3282(16)00013-2. doi: 10.1016/j.bone.2016.01.012.
- Tiidus PM, Lowe DA, Brown M; Estrogen replacement and skeletal muscle: mechanisms and population health. J Appl Physiol (1985). 2013 Sep 1115(5):569-78. doi: 10.1152/japplphysiol.00629.2013. Epub 2013 Jul 18.
- Archer DF; Postmenopausal skin and estrogen. Gynecol Endocrinol. 2012 Oct28 Suppl 2:2-6. Epub 2012 Aug 1.
- Doty RL, Tourbier I, Ng V, et al; Influences of hormone replacement therapy on olfactory and cognitive function in postmenopausal women. Neurobiol Aging. 2015 Jun36(6):2053-9. doi: 10.1016/j.neurobiolaging.2015.02.028. Epub 2015 Mar 10.
- Ibrahimi K, Couturier EG, MaassenVanDenBrink A; Migraine and perimenopause. Maturitas. 2014 Aug78(4):277-80. doi: 10.1016/j.maturitas.2014.05.018. Epub 2014 Jun 2.
- Beral V; Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003 Aug 9362(9382):419-27.
- Formoso G, Perrone E, Maltoni S, et al; Short and long term effects of tibolone in postmenopausal women. Cochrane Database Syst Rev. 2012 Feb 152:CD008536. doi: 10.1002/14651858.CD008536.pub2.
- Shapiro S, Farmer RD, Stevenson JC, et al; Does hormone replacement therapy (HRT) cause breast cancer? An application of causal principles to three studies. J Fam Plann Reprod Health Care. 2013 Apr39(2):80-8. doi: 10.1136/jfprhc-2012-100508.
- Chlebowski RT, Anderson GL; Menopausal hormone therapy and breast cancer mortality: clinical implications. Ther Adv Drug Saf. 2015 Apr6(2):45-56. doi: 10.1177/2042098614568300.
- Chlebowski RT, Anderson GL, Prentice RL, et al; Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy’s influence on incidence and deaths from breast cancer. Climacteric. 2015 Jun18(3):336-8. doi: 10.3109/13697137.2015.1038770.
- Lee E, Luo J, Su YC, et al; Hormone metabolism pathway genes and mammographic density change after quitting estrogen and progestin combined hormone therapy in the California Teachers Study. Breast Cancer Res. 2014 Dec 1116(6):477. doi: 10.1186/s13058-014-0477-8.
- Wachtel MS, Yang S, Dissanaike S, et al; Hormone Replacement Therapy, Likely Neither Angel Nor Demon. PLoS One. 2015 Sep 1810(9):e0138556. doi: 10.1371/journal.pone.0138556. eCollection 2015.
- Beral V, Gaitskell K, Hermon C, et al; Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet. 2015 May 9385(9980):1835-42. doi: 10.1016/S0140-6736(14)61687-1. Epub 2015 Feb 13.
- Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer; NICE Clinical Guideline (June 2013)
- Kaunitz AM, Manson JE; Management of Menopausal Symptoms. Obstet Gynecol. 2015 Oct126(4):859-76. doi: 10.1097/AOG.0000000000001058.
- Panay N; Body identical hormone replacement. Post Reprod Health. 2014 May 2220(2):69-72.
- Biglia N, Maffei S, Lello S, et al; Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials. Gynecol Endocrinol. 2010 Nov26(11):804-14. doi: 10.3109/09513590.2010.495437.